Mount Sinai launches AI-enabled center for pathology

Mount Sinai Health System has tapped Burlington, N.C.-based LabCorp to lead the integration of Philips' IntelliSite Pathology Solution into the New York City-based health system's hospitals.

Together, Mount Sinai and LabCorp will establish the Digital and Artificial Intelligence-Enabled Pathology Center of Excellence within the health system's department of pathology, molecular and cell-based medicine. The center will serve as a hub for the expansion of the digital pathology solution into primary diagnosis and consultations at Mount Sinai's eight hospitals and several ambulatory care facilities.

The AI-enabled Philips platform will initially be used at Mount Sinai for interpretations of genitourinary malignancies such as prostate tumors, as well as head and neck cancers. The next stage will see Mount Sinai's pathologists providing digital consultations for cases from LabCorp's Dianon Pathology, providing physicians and patients across the U.S. with access to the expertise of Mount Sinai's specialists.

"Digital pathology gives us the unprecedented opportunity to expand our services to the community at large and engage members of our department, considered key opinion leaders in their field, to provide expert diagnostic opinions in complex cases," said Carlos Cordon-Cardo, MD, PhD, chairman of Mount Sinai's department of pathology. "This, in addition to our new predictive AI-based tests, introduces the potential for optimization of treatment efficacy, and provides the opportunity for improved clinical outcomes."

More articles about AI:
Language analysis of Facebook posts accurately predicts diabetes, depression, psychosis & more
Investors, accelerators urge AI startups to implement code of ethics
Harvard Business Review: 3 ways AI marketplaces will change radiology

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Top 40 Articles from the Past 6 Months